Back to top

Guardant Health price target raised to $190 from $160 at Guggenheim

Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Guardant Health, Inc. (GH)